Publication Date
In 2025 | 0 |
Since 2024 | 0 |
Since 2021 (last 5 years) | 0 |
Since 2016 (last 10 years) | 0 |
Since 2006 (last 20 years) | 2 |
Descriptor
Drug Therapy | 2 |
Outcomes of Treatment | 2 |
Patients | 2 |
Seizures | 2 |
Adults | 1 |
Attention Deficit… | 1 |
Behavior Disorders | 1 |
Children | 1 |
Eating Habits | 1 |
Epilepsy | 1 |
Foreign Countries | 1 |
More ▼ |
Author
Banaschewski, Tobias | 1 |
Buitelaar, Jan | 1 |
Coghill, David | 1 |
Cortese, Samuele | 1 |
Danckaerts, Marina | 1 |
Dittmann, Ralf W. | 1 |
Graham, John | 1 |
Holtmann, Martin | 1 |
Marshall, Thomas | 1 |
Sergeant, Joseph | 1 |
Taylor, Eric | 1 |
More ▼ |
Publication Type
Information Analyses | 2 |
Journal Articles | 2 |
Reports - Research | 2 |
Education Level
Audience
Practitioners | 1 |
Location
Laws, Policies, & Programs
Assessments and Surveys
What Works Clearinghouse Rating
Cortese, Samuele; Holtmann, Martin; Banaschewski, Tobias; Buitelaar, Jan; Coghill, David; Danckaerts, Marina; Dittmann, Ralf W.; Graham, John; Taylor, Eric; Sergeant, Joseph – Journal of Child Psychology and Psychiatry, 2013
Background: Medication is an important element of therapeutic strategies for ADHD. While medications for ADHD are generally well-tolerated, there are common, although less severe, as well as rare but severe adverse events AEs during treatment with ADHD drugs. The aim of this review is to provide
evidence- and expert-based guidance concerning the…
Descriptors: Attention Deficit Hyperactivity Disorder, Therapy, Drug Therapy, Incidence
Marshall, Thomas – British Journal of Learning Disabilities, 2007
Background: Buccal midazolam is widely used in children for the emergency treatment of epilepsy, and these children are graduating into adult learning disability services. Aims: The aim of this paper was to appraise the evidence for buccal midazolam as a treatment for prolonged seizures in adults with learning disabilities. Method: A literature…
Descriptors: Patients, Seizures, Adults, Learning Disabilities